Sarasin & Partners’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-65,081
| Closed | -$243K | – | 84 |
|
|
2024
Q2 | $243K | Hold |
65,081
| – | – | ﹤0.01% | 83 |
|
|
2024
Q1 | $459K | Hold |
65,081
| – | – | ﹤0.01% | 80 |
|
|
2023
Q4 | $368K | Hold |
65,081
| – | – | ﹤0.01% | 84 |
|
|
2023
Q3 | $312K | Hold |
65,081
| – | – | ﹤0.01% | 79 |
|
|
2023
Q2 | $446K | Hold |
65,081
| – | – | 0.01% | 81 |
|
|
2023
Q1 | $507K | Hold |
65,081
| – | – | ﹤0.01% | 101 |
|
|
2022
Q4 | $495K | Hold |
65,081
| – | – | 0.01% | 90 |
|
|
2022
Q3 | $532K | Hold |
65,081
| – | – | 0.01% | 89 |
|
|
2022
Q2 | $629K | Buy |
+65,081
| New | +$629K | 0.01% | 88 |
|